Results 11 to 20 of about 35,187 (207)

A Metabolism Perspective on Pediatric Rhabdomyolysis

Trends in Pediatrics, 2021
Rhabdomyolysis is a clinical emergency that can result in life-threatening complications. The etiology for rhabdomyolysis is broad. Infecitons are the most common cause in pediatric patients.
Havva Yazıcı, Sema Kalkan Uçar
doaj   +2 more sources

Acute renal failure due to rhabdomyolysis following a seizure

Journal of Family Medicine and Primary Care, 2013
Acute renal failure, oliguric or nonoliguric, is the most common complication of rhabdomyolysis. Rhabdomyolysis should be suspected in patients presenting with states of increased muscular activity, such as seizures, agitation, strenuous muscle exercise,
Ajay Mishra, Nikhil Dave
doaj   +2 more sources

Rhabdomyolysis due to Lamivudine administration in acute viral hepatitis B infection: a case report from Malaysia

Electronic Physician, 2014
Rhabdomyolysis is a serious but rare side effect of Lamivudine treatment. Therefore, appropriate biochemical monitoring should be undertaken when it is used in the treatment of hepatitis B.
Janudin Baharin, Narisa Sulaiman Sahari, Sazlyna Mohd Sazlly Lim   +2 more
doaj   +2 more sources

Rhabdomyolysis in 114 patients with acute poisonings

Journal of Research in Medical Sciences, 2015
Background: Rhabdomyolysis is a clinical and biochemical syndrome, which is observed in some patients with acute chemical and/or pharmaceutical poisonings.
Seyed Reza Mousavi, Maryam Vahabzadeh, Adeleh Mahdizadeh, Mansooreh Vafaee, Mahmood Sadeghi, Reza Afshari, Mahdi Balali-Mood   +6 more
doaj   +1 more source

Pediatric COVID-19 Associated Rhabdomyolysis [PDF]

, 2021
The incidence of rhabdomyolysis secondary to various causes has been reported, especially for viral infections such as influenzas. It is well established that Coronavirus disease-2019 (COVID-19) can include a large array of symptoms during the disease ...
Parisa Armanpoor, Parvaneh Armanpoor
core   +1 more source

The management and diagnosis of rhabdomyolysis induced acute kidney injury: a case study [PDF]

, 2022
Rhabdomyolysis is characterised by a rapid dissolution of damaged or injured skeletal muscle which can be caused by a multitude of different mechanisms. It can range in severity from mild to severe leading to multi organ failure and death. Rhabdomyolysis
Mortimore, G., Torr, L.
core   +1 more source

Phenytoin-induced rhabdomyolysis [PDF]

, 2021
Rhabdomyolysis is a potentially life-threatening syndrome that can develop from a variety of causes. The most common causes are muscle injury, alcohol abuse, drugs, toxins and increased muscular activity.
Guler, Selda K., Guneş, Nalan, Çokal, Burcu G., Selda K. Guler, Burcu G. Çokal, Nalan Guneş   +5 more
core   +1 more source

Perioperative Rhabdomyolysis Following Prolonged Laparoscopic Radical Nephrectomy in the Lateral Decubitus Position. [PDF]

Clin Case Rep
ABSTRACT Perioperative rhabdomyolysis can occur after prolonged laparoscopic nephrectomy, particularly in obese patients positioned in the lateral decubitus position. In high‐risk patients undergoing prolonged surgery, early postoperative creatine kinase measurement is essential for timely diagnosis.
Dow M, Srinivasan A, Ayad S.
europepmc   +2 more sources

Exploring the association between selective serotonin reuptake inhibitors and rhabdomyolysis risk based on the FDA pharmacovigilance database

Scientific Reports, 2023
Rhabdomyolysis is a syndrome potentially fatal and has been associated with selective serotonin reuptake inhibitors (SSRIs) treatment in a few case reports.
Yan Wang, Yajing Lin, Qing Lin, Haiming Liang, Weiming Cai, Dongbo Jiang   +5 more
doaj   +1 more source

Phenotype standardization for statin-induced myotoxicity. [PDF]

, 2014
Statins are widely used lipid-lowering drugs that are effective in reducing cardiovascular disease risk. Although they are generally well tolerated, they can cause muscle toxicity, which can lead to severe rhabdomyolysis.
Fahy, J., Neely, D, Fahy, J, Wadelius, M, Carr, D. F., Maitland-van Der Zee, AH, Laaksonen, R, Maitland-van Der Zee, A. H., Wadelius, M., Yue, QY, Chinoy, H.; id_orcid, Psaty, BM, Bloch, K. M., Cooper, R. G., Neely, D., Psaty, B. M., Chinoy, H., Pirmohamed, M., Chinoy, H, Palmer, C. N. A., Voora, D, Palmer, C. N. A.; id_orcid, Voora, D., Armitage, J., Wadelius, Mia,, Yue, Q. Y., Alfirevic, A., Alfirevic, A, Armitage, J, Palmer, C. N A, Pirmohamed, M, Palmer, PN, Hanson, A., Bloch, KM, Laaksonen, R., Cooper, RG, Yue, Q-Y, Wadelius, Mia, Carr, DF, Hanson, A, Pharmacoepidemiology and Clinical Pharmacology, Sub Pharmacotherapy, Theoretical   +41 more
core   +1 more source